Infinium Pharmachem
Infinium Pharmachem Share Price Chart
Infinium Pharmachem last traded at ₹317.00 (2026-10-13). Over the past month the stock moved +15.7%, three months the stock moved +52.1%, year the stock moved +26.5%. Its closing range over 52 weeks is ₹199.35 – ₹317.00, with the latest close at its 52-week high.
Closing prices up to 2026-10-13.
About Infinium Pharmachem
Incorporated in 2003, Infinium Pharmachem Ltd manufactures and sells Iodian based Pharmaceutical Intermediates[1]
Business Overview:[1] IPL is a GMP compliant, FDA Approved and ISO 9001-2015 certified coimpany which does development, manufacture, and export of Iodine Derivatives & API. Currently, it has 250+ intermediates and 15+ APIs. It supplies a range of Iodine derivatives on Order to Made basis
Fundamentals
Quarterly Results
In the latest quarter (Mar 2026), Infinium Pharmachem reported sales of ₹106.00 crore (+43.2%) and net profit of ₹8.00 crore (+60.0%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 106.00 | 11.00 | 11.00 | 8.00 | 4.20 |
| Sep 2025 | 84.00 | 10.00 | 12.00 | 7.00 | 3.59 |
| Mar 2025 | 73.00 | 8.00 | 11.00 | 3.00 | 2.40 |
| Sep 2024 | 83.00 | 8.00 | 10.00 | 5.00 | 3.17 |
| Mar 2024 | 74.00 | 8.00 | 11.00 | 5.00 | 3.66 |
| Sep 2023 | 61.00 | 10.00 | 17.00 | 6.00 | 4.46 |
| Sep 2022 | 79.00 | 9.00 | 11.00 | 6.00 | 5.40 |
| Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|
| Sales growth | -7.6% | +37.7% | +43.2% |
| Operating profit growth | -11.1% | +0.0% | +37.5% |
| Net profit growth | -50.0% | +16.7% | +60.0% |
| EPS growth | -55.6% | -19.5% | +14.8% |
| OPM % | 11.0% | 12.0% | 11.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Infinium Pharmachem reported sales of ₹190.00 crore (+21.8%) and net profit of ₹14.00 crore (+75.0%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 190.00 | 22.00 | 11.00 | 14.00 | 7.80 |
| Mar 2025 | 156.00 | 16.00 | 11.00 | 8.00 | 5.23 |
| Mar 2024 | 136.00 | 19.00 | 14.00 | 12.00 | 8.12 |
| Mar 2023 | 114.00 | 16.00 | 14.00 | 10.00 | 9.30 |
| Mar 2022 | 99.00 | 10.00 | 10.00 | 7.00 | 30.55 |
| Mar 2021 | 71.00 | 5.00 | 7.00 | 3.00 | 13.60 |
| Mar 2020 | 39.00 | 2.00 | 6.00 | 1.00 | 4.65 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Sales growth | +82.1% | +39.4% | +15.2% | +19.3% | +14.7% | +21.8% |
| Operating profit growth | +150.0% | +100.0% | +60.0% | +18.8% | -15.8% | +37.5% |
| Net profit growth | +200.0% | +133.3% | +42.9% | +20.0% | -33.3% | +75.0% |
| EPS growth | +192.5% | +124.6% | -69.6% | -12.7% | -35.6% | +49.1% |
| OPM % | 7.0% | 10.0% | 14.0% | 14.0% | 11.0% | 11.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Infinium Pharmachem.
Get Free AI Stock Analysis FREE →Latest News
No recent news available for Infinium Pharmachem.
Frequently Asked Questions
What is Infinium Pharmachem's current stock price?
Infinium Pharmachem shares were last quoted at ₹317.00 (+1.4% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Infinium Pharmachem?
Infinium Pharmachem has a price-to-earnings (P/E) ratio of 26.32 and a price-to-book (P/B) ratio of 3.13. The industry P/E is 52.82.
What is the 52-week high and low of Infinium Pharmachem?
The 52-week high of Infinium Pharmachem is ₹285.50 and the 52-week low is ₹189.40.
What is the market cap of Infinium Pharmachem?
The market capitalisation of Infinium Pharmachem is about ₹373.65 crore.
How did Infinium Pharmachem perform in its latest quarterly results?
In the latest quarter (Mar 2026), Infinium Pharmachem reported sales of ₹106.00 crore (+43.2%) and net profit of ₹8.00 crore (+60.0%), compared with the same quarter last year.
Is Infinium Pharmachem a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Infinium Pharmachem has a 3-year ROE of 14.00%, 3-year profit growth of 9.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Infinium Pharmachem?
Promoters hold about 64.91% of Infinium Pharmachem.
Which sector does Infinium Pharmachem belong to?
Infinium Pharmachem belongs to the Chemicals sector.